Genocea biosciences, inc. (GNCA)
Balance Sheet / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13
Assets
Current assets:
Cash and cash equivalents

26,509

40,127

46,649

58,670

29,038

26,361

34,494

44,215

51,179

12,273

21,983

35,225

34,138

27,424

26,417

18,265

37,730

17,259

42,827

49,580

57,471

20,058

25,145

32,128

65,839

12,208

Investments, current portion

-

-

-

-

-

-

-

-

-

-

-

-

-

35,938

-

-

-

77,069

-

-

-

27,021

-

-

-

-

Investments, current portion

-

-

-

-

-

-

-

-

-

-

0

0

14,537

-

49,044

67,709

57,926

-

54,784

25,015

27,022

-

27,048

27,047

-

-

Prepaid expenses and other current assets

2,562

1,457

1,271

1,062

1,537

696

1,884

1,269

1,378

808

1,309

1,726

1,443

926

950

1,342

1,561

865

883

770

1,132

934

1,328

1,141

944

510

Restricted Cash and Cash Equivalents, Current

-

-

-

-

316

-

-

-

-

-

-

-

-

-

-

-

316

-

-

-

-

-

-

-

157

157

Total current assets

29,071

41,584

47,920

59,732

30,891

27,057

36,378

45,484

52,557

13,081

23,292

36,951

50,118

64,288

76,411

87,316

97,533

95,193

98,494

75,365

85,625

48,013

53,521

60,316

66,940

12,875

Property and equipment, net

2,474

2,617

2,896

2,813

2,531

2,582

2,836

3,069

3,172

3,460

4,000

4,909

4,782

4,871

5,034

4,877

4,751

4,083

3,674

2,557

2,137

1,956

1,874

1,073

814

865

Right of use assets

11,782

6,306

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Operating Lease, Right-of-Use Asset

-

-

6,516

6,840

1,342

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Restricted cash

631

631

631

316

0

316

316

316

316

316

316

316

316

316

316

316

0

316

316

316

316

316

316

316

316

158

Investments, net of current portion

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

12,104

-

-

-

0

-

-

-

-

Investments, net of current portion

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

14,934

-

-

-

-

-

-

-

Other non-current assets

1,234

1,473

1,324

1,061

1,060

1,160

171

171

419

631

436

436

429

421

1,108

355

371

446

462

478

338

47

88

145

143

1,863

Total assets

45,192

52,611

59,287

70,762

35,824

31,115

39,701

49,040

56,464

17,488

28,044

42,612

55,645

69,896

82,869

92,864

102,655

112,142

117,880

78,716

88,416

50,332

55,799

61,850

68,213

15,761

Liabilities and stockholders’ equity
Current liabilities:
Accounts payable

860

553

686

1,247

1,811

1,659

1,276

1,656

2,094

3,516

2,129

2,463

2,875

3,043

1,888

1,115

2,151

1,757

1,731

1,411

2,758

2,692

1,522

1,209

1,263

2,176

Accrued expenses and other current liabilities

4,077

4,611

4,111

5,050

2,965

3,816

4,233

3,075

4,427

5,604

6,321

3,584

2,440

4,178

3,641

3,046

2,911

3,975

4,928

4,160

3,262

2,593

2,087

1,449

1,483

1,418

Lease liabilities

2,028

1,117

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Operating lease liabilities

-

-

1,017

1,045

1,432

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

235

457

670

556

555

766

30

12

12

Current portion of long-term debt

7,700

-

5,256

2,673

6,115

5,257

3,574

1,924

0

6,659

6,538

6,419

4,771

3,149

1,559

-

-

0

1,100

-

1,102

0

3,376

2,679

1,770

861

Other current liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

134

125

-

0

-

-

-

-

Current portion of deferred rent

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

116

-

99

43

17

26

Total current liabilities

14,665

6,281

11,070

10,015

12,323

10,732

9,083

6,655

6,521

15,779

14,988

12,466

10,086

10,370

7,088

4,161

5,062

5,967

8,350

6,366

7,794

5,840

7,850

5,410

4,545

4,493

Non-current liabilities:
Long-term debt, net of current portion

5,815

13,407

8,041

11,059

8,007

9,565

11,064

12,544

13,874

7,652

9,244

10,795

12,312

13,809

15,274

16,710

16,592

16,477

10,558

11,564

10,480

11,389

6,254

7,147

8,040

8,933

Warrant liability

1,705

2,486

3,183

-

9,259

3,472

13,021

15,915

21,414

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Lease liabilities, net of current portion

9,994

5,395

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Operating lease liabilities, net of current portion

-

-

5,620

5,861

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accrued interest payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

70

48

25

11

Deferred rent, net of current portion

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

136

-

196

210

230

237

Deferred revenue, net of current portion

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

228

350

448

-

-

-

Other non-current liabilities

-

-

0

0

0

11

35

61

87

107

126

144

163

176

158

127

11

37

87

124

32

246

17

-

-

-

Warrants to purchase redeemable securities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

656

Total liabilities

32,179

27,569

27,914

32,324

29,589

23,780

33,203

35,175

41,896

23,538

24,358

23,405

22,561

24,355

22,520

20,998

21,665

22,481

18,995

18,054

18,670

17,825

14,835

12,815

12,840

14,330

Commitments and contingencies (Note 5)

-

-

-

-

-

-

0

0

0

-

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

Stockholders’ equity:
Preferred stock, $0.001 par value; (shares authorized of 25,000,000 at March 31, 2020 and December 31, 2019; 1,635 shares issued and outstanding at March 31, 2020 and December 31, 2019)

701

701

701

701

701

701

702

702

702

0

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

Preferred stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

Common stock, $0.001 par value; (shares authorized of 85,000,000 and 250,000,000 at December 31, 2019 and 2018; 27,452,900 shares issued and outstanding at December 31, 2019 and 10,846,397 shares issued and outstanding at December 31, 2018)

-

-

-

-

-

11

-

-

-

29

-

-

-

28

-

-

-

28

28

24

24

18

18

17

17

-

Additional paid-in capital

-

-

-

-

-

298,627

-

-

-

258,114

-

-

-

252,996

-

-

-

247,550

246,436

198,456

197,229

147,923

144,713

143,625

142,816

-

Common stock, $0.001 par value; (shares authorized of 85,000,000 at March 31, 2020 and December 31, 2019, 27,643,773 shares issued and outstanding at March 31, 2020 and 27,452,900 shares issued and outstanding at December 31, 2019)

28

27

26

26

112

-

87

87

83

-

29

29

29

-

28

28

28

-

-

-

-

-

-

-

-

-

Additional paid-in capital

356,091

355,268

352,244

351,777

312,993

-

298,063

297,597

293,866

-

257,118

255,771

254,276

-

251,762

250,505

248,623

-

-

-

-

-

-

-

-

-

Accumulated other comprehensive loss

-

-

-

-

-

-

-

-

-

-

-

-

-3

-

8

17

0

-7

17

7

4

-7

10

-1

-

-

Accumulated deficit

-343,807

-330,954

-321,598

-314,066

-307,571

-292,004

-292,354

-284,521

-280,083

-264,193

-253,461

-236,593

-221,218

-207,483

-191,449

-178,684

-167,661

-157,910

-147,596

-137,825

-127,511

-115,427

-103,777

-94,606

-87,460

-80,131

Total stockholders’ equity

13,013

25,042

31,373

38,438

6,235

7,335

6,498

13,865

14,568

-6,050

3,686

19,207

33,084

45,541

60,349

71,866

80,990

89,661

98,885

60,662

69,746

32,507

40,964

49,035

55,373

-80,131

Total liabilities and stockholders’ equity

45,192

52,611

59,287

70,762

35,824

31,115

39,701

49,040

56,464

17,488

28,044

42,612

55,645

69,896

82,869

92,864

102,655

112,142

117,880

78,716

88,416

50,332

55,799

61,850

68,213

15,761